Skip to main content
. 2019 Aug 24;35(4):823–832. doi: 10.1007/s10103-019-02863-9

Table 4.

Quality of life (SF-36 scores) over time according to group

SF-36 dimensions Time point Laser moxibustion (n = 84) Traditional moxibustion (n = 55) P value*
PF (physical functioning) Baseline 60 (40, 70) 60 (45, 70) 0.713
Mid-term 65 (50, 80) 62.5 (50, 70)
End of treatment 67.5 (55, 80) 65 (53.75, 75)
Follow-up 70 (56.25, 80) 60 (53.75, 71.25)
RP (role-physical) Baseline 0 (0, 50) 25 (0, 56.25) 0.140
Mid-term 25 (0, 75) 37.5 (0, 100)
End of treatment 25 (0, 50) 25 (0, 75)
Follow-up 25 (0, 75) 25 (0, 75)
RE (role-emotional) Baseline 33.33 (0, 100) 33.33 (0, 100) 0.152
Mid-term 33.33 (0, 100) 66.67 (0, 100)
End of treatment 33.33 (0, 100) 66.67 (0, 100)
Follow-up 33.33 (0, 100) 33.33 (0, 100)
VT (vitality) Baseline 45 (30, 55) 55 (40, 65) 0.006
Mid-term 45 (65, 60) 55 (45, 60)
End of treatment 50 (40, 60) 60 (45, 70)
Follow-up 50 (35, 65) 60 (45, 70)
MH (mental health) Baseline 64 (48, 79) 72 (64, 84) 0.002
Mid-term 64 (52, 76) 72 (60, 80)
End of treatment 64 (56, 75) 68 (60, 76)
Follow-up 68 (60, 80) 64 (56, 80)
SF (social functioning) Baseline 75 (62.5, 87.5) 75 (62.5, 100) 0.039
Mid-term 75 (62.5, 87.5) 75 (62.5, 87.5)
End of treatment 75 (62.5, 84.38) 75 (62.5, 87.5)
Follow-up 75 (62.5, 87.5) 75 (62.5, 87.5)
BP (bodily pain) Baseline 55 (35, 59.38) 67.5 (45, 67.5) < 0.001
Mid-term 57.5 (45, 67.5) 67.5 (55, 67.5)
End of treatment 67.5 (55, 67.5) 67.5 (57.5, 77.5)
Follow-up 67.5 (57.5, 75) 67.5 (55, 77.5)
GH (General Health) Baseline 35 (30, 50) 50 (35, 60) 0.001
Mid-term 40 (30, 55) 45 (35, 55)
End of treatment 40 (31.25, 55) 55 (35, 65)
Follow-up 45 (35, 58.75) 50 (45, 65)

*P values were only presented for the comparison of baseline between the two groups